Abstract: Peripheral vascular disease is a widespread clinical problem, accounting for more than one million vascular graft surgeries each year in the United States. To date, attempts to develop a ...

For the last 23 years, Christopher Breuer, MD, and Toshiharu Shinoka, MD, PhD, co-directors of the Tissue Engineering Program at Nationwide Children’s Hospital, have been working together to use ...

Xcellerex will leverage its XDR bioreactors and FlexFactory platform to allow future scale-up. Xcellerex and Humacyte signed a collaboration agreement under which Xcellerex will develop a single-use ...

GORE Hybrid Vascular Graft is a surgically implantable, ePTFE vascular prosthesis with a section reinforced with nitinol. It is intended for use as a blood conduit for a permanent replacement of ...

MADISON — Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell ...

Applying a molecule derived from seaweed to synthetic vascular grafts improves in situ endothelialization and could lead to better bypass surgery outcomes. A recent paper from scientists at the ...

In a study published in the journal Burns & Trauma, researchers from Shanghai Jiao Tong University and Donghua University developed a new type of vascular graft using 3D printing and electrospinning.

WAYNE, N.J. -- MAQUET Cardiovascular, LLC announced today that it has received CE mark for its INTERGARD SYNERGY vascular graft. This graft represents the next generation in antimicrobial grafts ...

A team of researchers at Cornell University has developed a new biodegradable vascular graft that could transform the treatment of cardiovascular disease, the leading cause of death worldwide. Anova ...

ALBANY, N.Y., April 27, 2021 /PRNewswire/ -- Vascular grafts are commonly used in endovascular surgeries, and both autologous veins and arteries can be used as conduit. The drive for improving the ...

SAN FRANCISCO (MarketWatch) -- Angiotech Pharmaceuticals Inc. said Thursday that it has agreed to pay $14 million cash for Edwards Lifesciences Corp.'s Lifespan ePTFE vascular graft business. The deal ...